The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

L.K. Moshetova

Russian Medical Academy of Postgraduate Education, Ophthalmology Department, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 123242, City Clinical Hospital named after S.P. Botkin, Branch №1, Moscow Health Department, 7 Mamonovskiy pereulok, Moscow, Russian Federation, 123001

I.V. Vorob'eva

Kafedra oftal'mologii i kafedra biokhimii GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia" Minzdravsotsrazvitiia Rossii, Moskva

I.B. Alekseev

Kafedra oftal'mologii GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia" Ministerstva zdravookhraneniia Rossii

L.G. Mikhaleva

Kafedra oftal'mologii GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia" Ministerstva zdravookhraneniia Rossii

Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration

Authors:

L.K. Moshetova, I.V. Vorob'eva, I.B. Alekseev, L.G. Mikhaleva

More about the authors

Journal: Russian Annals of Ophthalmology. 2015;131(3): 34‑44

Views: 793

Downloaded: 16


To cite this article:

Moshetova LK, Vorob'eva IV, Alekseev IB, Mikhaleva LG. Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration. Russian Annals of Ophthalmology. 2015;131(3):34‑44. (In Russ.)
https://doi.org/10.17116/oftalma2015131334-44

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.